CAS No |
Product Name |
Molecular Formula |
898537-18-3
|
Luseogliflozin
|
C23H30O6S
|
898537-77-4
|
3-(1,1-Dimethylethyl)-1-(3-methylphenyl)-1H-pyrazol-5-amine
|
C14H19N3
|
898538-17-5
|
Dapagliflozin Impurity 71
|
C15H15BrO
|
898542-80-8
|
Salbutamol EP Impurity K
|
C13H18ClNO3
|
898542-81-9
|
Salbutamol EP Impurity L
|
C13H20ClNO3
|
898543-06-1
|
4-[4-[(5S)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone hydrochloride
|
C14H17N3O4.HCl
|
898546-82-2
|
9-(4-tert-Butylphenyl)-3,6-bis(triphenylsilyl)-9H-carbazole
|
C58H49NSi2
|
898562-94-2
|
PF-2545920
|
C25H20N4O
|
898563-00-3
|
2-[(4-[4-(Pyridin-4-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazol-3-yl]phenoxy)methyl]quinoline
|
C26H19F3N4O
|
898566-17-1
|
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene
|
C18H14FIS
|
898656-60-5
|
6-Chloro-N-(3-methoxypropyl)-3-pyridazinamine
|
C8H12ClN3O
|
898745-39-6
|
1-(3-Furanylcarbonyl)pyrrolidine
|
C9H11NO2
|
898746-42-4
|
6-Fluoro-1H-pyrrolo[2,3-b]pyridine
|
C7H5FN2
|
898746-82-2
|
6-Hydroxyindole-1-carboxylic acid tert-butyl ester
|
C13H15NO3
|
898746-91-3
|
6-Bromo-1H-indole-4-carboxylic acid
|
C9H6BrNO2
|
898747-00-7
|
6-Bromo-1H-indazole-4-carbonitrile
|
C8H4BrN3
|
898747-24-5
|
Methyl 5-bromo-1H-indazole-7-carboxylate
|
C9H7BrN2O2
|
898747-36-9
|
1H-Indazole-3,7-dicarboxylic acid 7-methyl ester
|
C10H8N2O4
|
898747-94-9
|
4,7-Dibromo-2-chlorobenzothiazole
|
C7H2Br2ClNS
|
898748-23-7
|
2-Bromo-6-(trifluoromethyl)benzothiazole
|
C8H3BrF3NS
|
898759-50-7
|
(4-Methoxyphenyl)-2-oxazolylmethanone
|
C11H9NO3
|
898800-26-5
|
2-(1,1-Dimethylethyl)-5-phenyl-4-[[4-(1-piperidinyl)phenyl]amino]-3(2H)-isothiazolone 1,1-dioxide
|
C24H29N3O3S
|
898832-40-1
|
8-Fluoro-3,4-dihydro-2H-benzo[1,4]oxazine
|
C8H8FNO
|
898838-07-8
|
Dichloro(2,2,6,6-tetramethylpiperidinato)magnesate(1-) lithium (1:1)
|
C9H18Cl2MgN.Li
|
899233-16-0
|
1-[(2,4-Difluorophenyl)sulfonyl]-1H-pyrazole
|
C9H6F2N2O2S
|
899350-32-4
|
3-Bromobenzenebutanoic acid
|
C10H11BrO2
|
899422-06-1
|
2-Bromospiro[9H-fluorene-9,9'-[9H]xanthene]
|
C25H15BrO
|
899429-04-0
|
6-Bromo-8-methyl-[1,2,4]triazolo[1,5-a]pyridine
|
C7H6BrN3
|
899431-18-6
|
3-[[5-(2,3-Dichlorophenyl)-1H-tetrazol-1-yl]methyl]pyridine monohydrochloride
|
C13H9Cl2N5.HCl
|
899436-71-6
|
2-Methylpyridine-3-boronic acid
|
C6H8BNO2
|
899438-92-7
|
6-Isoquinolinylboronic acid
|
C9H8BNO2
|
899452-26-7
|
5-Bromo-2-(difluoromethoxy)pyridine
|
C6H4BrF2NO
|
899507-36-9
|
3-[[5-(2,3-Dichlorophenyl)-1H-tetrazol-1-yl]methyl]pyridine
|
C13H9Cl2N5
|
899713-86-1
|
N-[2-Chloro-5-(trifluoromethyl)phenyl]-4-(2-furanylcarbonyl)-1-piperazineacetamide
|
C18H17ClF3N3O3
|
899795-65-4
|
5-Chloro-3-benzofurancarboxylic acid ethyl ester
|
C11H9ClO3
|
899805-25-5
|
Tanzisertib
|
C21H23F3N6O2
|
899806-25-8
|
(2-Chloro-6-fluorophenyl)isothiocyanate
|
C7H3ClFNS
|
899809-61-1
|
(4R)-4-Hydroxy-N,N-diphenyl-2-pentynamide
|
C17H15NO2
|
899809-64-4
|
(2E)-3-(5-Nitro-1-cyclohexen-1-yl)-2-propenoic acid
|
C9H11NO4
|
899821-23-9
|
2-Chloro-4-[(1R,5S)-3-hydroxy-3-methyl-8-azabicyclo[3.2.1]octan-8-yl]-3-methylbenzonitrile
|
C16H19ClN2O
|
899822-97-0
|
3-Nitro-1-(4-octylphenyl)-1-propanone
|
C17H25NO3
|
899822-99-2
|
3-(Hydroxymethyl)-3-nitro-1-(4-octylphenyl)-1,4-butanediol
|
C19H31NO5
|
899827-82-8
|
6-Amino-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-1,9-dihydro-2H-purin-2-one
|
C10H12FN5O4
|
899831-69-7
|
L-Phenylalanyl-L-seryl-L-asparaginyl-L-seryl-L-threonyl-L-asparaginyl-L-alpha-aspartyl-L-isoleucyl-L-leucyl-L-isoleucine
|
C49H78N12O18
|
899899-13-9
|
1-(2,2,2-Trifluoroethyl)-1H-pyrazol-5-amine
|
C5H6F3N3
|
900015-35-2
|
4-(2-Methyl-1H-imidazol-1-yl)benzoic acid methyl ester
|
C12H12N2O2
|
900019-52-5
|
4-Amino-3-bromo-5-methylbenzoic acid methyl ester
|
C9H10BrNO2
|
900021-53-6
|
5-Fluoro-2-methoxybenzenepropanoic acid
|
C10H11FO3
|
900027-15-8
|
4-Chloro-3-(trifluoromethyl)benzenepropanoic acid
|
C10H8ClF3O2
|
900027-23-8
|
5-Bromo-2-thiophenepropanoic acid
|
C7H7BrO2S
|